101 related articles for article (PubMed ID: 22487785)
1. Aminopyridine treatment in a patient with bilateral vestibular failure and cryptogenic downbeat nystagmus.
Spiegel R; Kalla R; Classen J; Bardins S; Anciães da Silva F; Farahmand P; Hahn A; Schneider E; Rettinger N; Jahn K; Brandt T; Strupp M
J Neuroophthalmol; 2012 Jun; 32(2):190. PubMed ID: 22487785
[No Abstract] [Full Text] [Related]
2. Comparison of 10-mg doses of 4-aminopyridine and 3,4-diaminopyridine for the treatment of downbeat nystagmus.
Kalla R; Spiegel R; Claassen J; Bardins S; Hahn A; Schneider E; Rettinger N; Glasauer S; Brandt T; Strupp M
J Neuroophthalmol; 2011 Dec; 31(4):320-5. PubMed ID: 21734596
[TBL] [Abstract][Full Text] [Related]
3. Potassium channels, the cerebellum, and treatment for downbeat nystagmus.
Leigh RJ
Neurology; 2003 Jul; 61(2):158-9. PubMed ID: 12874391
[No Abstract] [Full Text] [Related]
4. Beneficial effects of 3,4-diaminopyridine on positioning downbeat nystagmus in a circumscribed uvulo-nodular lesion.
Helmchen C; Gottschalk S; Sander T; Trillenberg P; Rambold H; Sprenger A
J Neurol; 2007 Aug; 254(8):1126-8. PubMed ID: 17410325
[No Abstract] [Full Text] [Related]
5. Effect of 3,4-diaminopyridine on the postural control in patients with downbeat nystagmus.
Sprenger A; Zils E; Rambold H; Sander T; Helmchen C
Ann N Y Acad Sci; 2005 Apr; 1039():395-403. PubMed ID: 15826992
[TBL] [Abstract][Full Text] [Related]
6. Effect of 3,4-diaminopyridine on the gravity dependence of ocular drift in downbeat nystagmus.
Helmchen C; Sprenger A; Rambold H; Sander T; Kömpf D; Straumann D
Neurology; 2004 Aug; 63(4):752-3. PubMed ID: 15326263
[No Abstract] [Full Text] [Related]
7. 4-aminopyridine improves downbeat nystagmus, smooth pursuit, and VOR gain.
Kalla R; Glasauer S; Schautzer F; Lehnen N; Büttner U; Strupp M; Brandt T
Neurology; 2004 Apr; 62(7):1228-9. PubMed ID: 15079036
[No Abstract] [Full Text] [Related]
8. Upbeat about downbeat nystagmus.
Halmagyi GM; Leigh RJ
Neurology; 2004 Aug; 63(4):606-7. PubMed ID: 15326227
[No Abstract] [Full Text] [Related]
9. Transition from downbeat to upbeat nystagmus caused by 4-aminopyridine.
Feil K; Claaßen J; Bardins S; Teufel J; Habs M; Kalla R; Strupp M
J Neurol; 2013 May; 260(5):1426-8. PubMed ID: 23595790
[No Abstract] [Full Text] [Related]
10. Clinical use of 4-aminopyridine in patients with downbeat nystagmus.
Domínguez-Durán E; Mármol-Szombathy I; Baños-Roldán Ú; Sánchez-Gómez S
Acta Otorrinolaringol Esp (Engl Ed); 2020; 71(1):40-44. PubMed ID: 31078225
[TBL] [Abstract][Full Text] [Related]
11. 18F-fluorodeoxyglucose hypometabolism in cerebellar tonsil and flocculus in downbeat nystagmus.
Bense S; Best C; Buchholz HG; Wiener V; Schreckenberger M; Bartenstein P; Dieterich M
Neuroreport; 2006 Apr; 17(6):599-603. PubMed ID: 16603919
[TBL] [Abstract][Full Text] [Related]
12. Treatment of downbeat nystagmus with 3,4-diaminopyridine: a placebo-controlled study.
Strupp M; Schüler O; Krafczyk S; Jahn K; Schautzer F; Büttner U; Brandt T
Neurology; 2003 Jul; 61(2):165-70. PubMed ID: 12874393
[TBL] [Abstract][Full Text] [Related]
13. No benefit of 3,4-diaminopyridine in essential tremor: a placebo-controlled crossover study.
Lorenz D; Hagen K; Ufer M; Cascorbi I; Deuschl G; Volkmann J
Neurology; 2006 Jun; 66(11):1753-5. PubMed ID: 16769957
[TBL] [Abstract][Full Text] [Related]
14. Dalfampridine in patients with downbeat nystagmus--an observational study.
Claassen J; Feil K; Bardins S; Teufel J; Spiegel R; Kalla R; Schneider E; Jahn K; Schniepp R; Strupp M
J Neurol; 2013 Aug; 260(8):1992-6. PubMed ID: 23589193
[TBL] [Abstract][Full Text] [Related]
15. Update on the pharmacotherapy of cerebellar and central vestibular disorders.
Kalla R; Teufel J; Feil K; Muth C; Strupp M
J Neurol; 2016 Apr; 263 Suppl 1():S24-9. PubMed ID: 27083881
[TBL] [Abstract][Full Text] [Related]
16. [Pharmacological treatment of nystagmus].
Pieh-Beisse C; Lagrèze WA
Ophthalmologe; 2011 Feb; 108(2):178-82. PubMed ID: 21253746
[TBL] [Abstract][Full Text] [Related]
17. 4-aminopyridine restores vertical and horizontal neural integrator function in downbeat nystagmus.
Kalla R; Glasauer S; Büttner U; Brandt T; Strupp M
Brain; 2007 Sep; 130(Pt 9):2441-51. PubMed ID: 17664175
[TBL] [Abstract][Full Text] [Related]
18. A randomized trial of 4-aminopyridine in EA2 and related familial episodic ataxias.
Hess E
Neurology; 2011 Nov; 77(22):1996-7; author reply 1997. PubMed ID: 22123782
[No Abstract] [Full Text] [Related]
19. Medical treatment of acquired nystagmus.
Ehrhardt D; Eggenberger E
Curr Opin Ophthalmol; 2012 Nov; 23(6):510-6. PubMed ID: 23014266
[TBL] [Abstract][Full Text] [Related]
20. 4-Aminopyridine suppresses positional nystagmus caused by cerebellar vermis lesion.
Kremmyda O; Zwergal A; la Fougère C; Brandt T; Jahn K; Strupp M
J Neurol; 2013 Jan; 260(1):321-3. PubMed ID: 23180177
[No Abstract] [Full Text] [Related]
[Next] [New Search]
